Alix Ventures — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
64x Bio develops cell-line engineering and production technologies to overcome manufacturing bottlenecks in advanced and next-generation therapies.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSan Francisco, US
Lexi Rovner(CEO, Co-founder, Board of Directors)inAlexis Rovner(Founder)Ryan GallagherEmily Hawkins(Head of Talent)George Church, PhD(Co-founder, Scientific Advisory Board)David Thompson, PhD(Co-founder, Scientific Advisory Board)
Co-investorsFifty YearsFuture VenturesG VenturesLifeforce CapitalRaptor GroupY Combinator+8 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.


